佛罗里达州的一项试验试验用胆固醇药物inclisiran, 治疗动脉堵塞的患者, 以预防心脏病发作和中风. A Florida trial tests inclisiran, a cholesterol drug, in patients with blocked arteries to prevent heart attacks and strokes.

佛罗里达州戴托纳海的Arrow临床试验正在招募心脏或腿部动脉堵塞的患者, 那些患者最近接受了血管整形手术, 或计划在14天内接受血管整形手术, 为了研究FDA批准的胆固醇药物inclisirin, 用于预防心脏病发作,中风或四肢. Arrow Clinical Trials in Daytona Beach, Florida, is enrolling patients with blocked heart or leg arteries who recently had or are scheduled for angioplasty within 14 days to study inclisirin, an FDA-approved cholesterol drug, for preventing heart attacks, strokes, or limb gangrene. 参与者必须继续使用处方心脏药物。 Participants must continue prescribed heart medications. 首席研究员查尔斯·罗斯博士 说这次试验可以减少严重的心血管并发症 Dr. Charles Ross, the lead researcher, said the trial could reduce serious cardiovascular complications. 感兴趣的个人可联系该网站386-278-8000或与其医生交谈。 Interested individuals can contact the site at 386-278-8000 or speak with their doctor.